Although confirmation awaits further investigation, these results suggest that the CERT1 degradation induced by the degraders may be involved in the sensitization
Whilst there is no universal guidance mandating routine B12 monitoring specifically for GLP-1/GIP users, clinical judgement should guide individualised monitoring
In addition, studies are investigating their broader benefits in patients with chronic kidney disease (CKD) and in elderly populations, with the aim of improving overall health outcomes in these high-risk groups Table 3
Among various factors, the guideline dismisses routine testing to achieve certain levels that are specific to each healthy individual and must be personalized rather than standardized
GLP-1R mRNA is most abundant in islets and lung with lesser amounts in the stomach
Some people achieve their target weight loss within 6-12 months, while others require 12-24 months or see more modest but still meaningful reductions of 10-15%